Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.0646360796409868e-78,187.4227074235808,33525.55227440197,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.288165361132683e-76,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.5847947998604519e-52,51.16674322462104,6102.86059128276,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.7971628217536977e-50,0,0,60
3,Oxidative phosphorylation WP623,7.21191019311532e-33,59.89789520824004,4433.017720794296,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",8.48601432723236e-31,0,0,36
4,Nonalcoholic fatty liver disease WP4396,3.743614009899838e-29,11.573396426924388,757.5356937270813,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",3.303739363736607e-27,0,0,52
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.9014562154565398e-27,57.876427829698855,3560.973247509267,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.342428088112317e-25,0,0,30
6,Mitochondrial CIV Assembly WP4922,2.1292775581477847e-17,38.18773552586502,1465.957047789204,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14', 'COX20']",1.2527249633769468e-15,0,0,20
7,Mitochondrial complex III assembly WP4921,2.766051147162483e-08,33.99390243902439,591.6047232238162,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.394880078497652e-06,0,0,9
8,Cellular Proteostasis WP4918,2.944509344777803e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",1.2992647483832057e-05,0,0,6
9,mRNA Processing WP411,1.0571580089226899e-05,4.332407272018326,49.637868684464856,"['SF3B5', 'DHX8', 'NCBP2', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.0004146408634996772,0,0,16
10,Nucleotide Excision Repair WP4753,0.00019088160568937472,5.658028455284553,48.454547654515125,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.006738120680834927,0,0,9
11,DNA Mismatch Repair WP531,0.0004977731206416777,8.468844984802432,64.40866711072829,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2']",0.015973991962410203,0,0,6
12,Translation Factors WP107,0.0005755107510239614,4.192004822727101,31.27341508248345,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF1AY', 'EIF3I', 'EIF4H', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.016929607925954868,0,0,10
13,Pyrimidine metabolism WP4022,0.0009601750383012695,3.3152830610874915,23.035896107856207,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.026072445270796007,0,0,12
14,Computational Model of Aerobic Glycolysis WP4629,0.0010994472858430956,9.401990553306343,64.05526984855499,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.02772177799304377,0,0,5
15,Cholesterol Biosynthesis Pathway WP197,0.0017585574132162327,8.058126084441874,51.11480061201633,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.038798172929083136,0,0,5
16,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0017585574132162327,8.058126084441874,51.11480061201633,"['EIF3I', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.038798172929083136,0,0,5
17,VEGFA-VEGFR2 Signaling Pathway WP3888,0.003433435206370171,1.7105015673981192,9.705717732596657,"['RPL5', 'SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'TFCP2', 'CYCS', 'RPL27', 'RPL26', 'EIF3F', 'CALR', 'ALDOA', 'EIF3D', 'PTMA']",0.07129427222639237,0,0,36
18,Proteasome Degradation WP183,0.00424620116232564,3.28147128245476,17.922511919258145,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMA2', 'PSME1', 'PSMB10', 'PSMA7']",0.0805239888951825,0,0,9
19,Ciliary landscape WP4352,0.004334152376794526,2.0635335887134447,11.228159255271917,"['NUDC', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'EXOSC4', 'RAB14', 'MFAP1', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.0805239888951825,0,0,20
20,Synaptic Vesicle Pathway WP2267,0.0062321379407631935,3.346794510246287,16.995142460063445,"['RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.10999723465447035,0,0,8
21,Glycolysis and Gluconeogenesis WP534,0.008842237239488751,3.1154209697181865,14.73038125996175,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'ALDOA', 'PFKM']",0.13853899479147913,0,0,8
22,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.009026620057235184,11.262626262626263,53.019683542501646,"['ELOB', 'ELOC', 'RBX1']",0.13853899479147913,0,0,3
23,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.009026620057235184,11.262626262626263,53.019683542501646,"['IDI1', 'HMGCS1', 'PMVK']",0.13853899479147913,0,0,3
24,Photodynamic therapy-induced unfolded protein response WP3613,0.012594850971575323,4.336655247586422,18.97055614519466,"['NARS', 'XBP1', 'DDIT3', 'CALR', 'HSP90B1']",0.18524926637358705,0,0,5
25,Dual hijack model of Vif in HIV infection WP3300,0.014843284619350037,8.44621212121212,35.5603075636217,"['ELOB', 'ELOC', 'RBX1']",0.20958717882522251,0,0,3
26,Cori Cycle WP1946,0.017449384079069832,5.007976631839119,20.274547638990725,"['LDHA', 'TPI1', 'PGK1', 'ALDOA']",0.23690894538121735,0,0,4
27,Mevalonate pathway WP3963,0.018943230560790156,22.506559031281533,89.26795948882592,"['HMGCS1', 'PMVK']",0.24177791141576588,0,0,2
28,DNA Repair Pathways Full Network WP4946,0.01917785133042902,2.2197228687809134,8.77678254143136,"['POLE4', 'POLD4', 'RFC3', 'NEIL2', 'CENPX', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.24177791141576588,0,0,11
29,Selenium Micronutrient Network WP15,0.020271838104419685,2.3053127660016193,8.987314014232336,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.24675720175379823,0,0,10
30,Melanoma WP4685,0.021542025146617755,2.5799564902102974,9.901226972131395,"['CCND1', 'BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.2534778292252023,0,0,8
31,Ferroptosis WP4313,0.023296138515276357,3.075711522520033,11.563038003796365,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.2609536358067577,0,0,6
32,Base Excision Repair WP4752,0.024395099098082164,3.5225835020242915,13.080666549419748,"['POLE4', 'POLD4', 'NEIL2', 'POLD2', 'POLE3']",0.2609536358067577,0,0,5
33,Eukaryotic Transcription Initiation WP405,0.024395099098082164,3.5225835020242915,13.080666549419748,"['GTF2A2', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.2609536358067577,0,0,5
34,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.02740479266440386,2.9417206290471785,10.581479023382412,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.2845262297216048,0,0,6
35,Androgen receptor signaling pathway WP138,0.03304052470895138,2.208443796394486,7.530838507130701,"['CCND1', 'SUMO1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.33323729206456676,0,0,9
36,Amyotrophic lateral sclerosis (ALS) WP2447,0.03524419273032256,3.1306230319388213,10.473356936723,"['TOMM40', 'BAD', 'NEFL', 'BAX', 'SOD1']",0.34193395028843204,0,0,5
37,Gastric acid production WP2596,0.03584010243816427,11.252270433905146,37.45529568327251,"['CCK', 'VIP']",0.34193395028843204,0,0,2
38,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.05653051186991212,7.500840901446351,21.549726539870655,"['COX8A', 'COX5A']",0.4988817672519744,0,0,2
39,Trans-sulfuration pathway WP2333,0.05653051186991212,7.500840901446351,21.549726539870655,"['AHCY', 'GOT1']",0.4988817672519744,0,0,2
40,Peroxiredoxin 2 induced ovarian failure WP4873,0.05653051186991212,7.500840901446351,21.549726539870655,"['STAR', 'BAX']",0.4988817672519744,0,0,2
41,7q11.23 copy number variation syndrome WP4932,0.06372674438405034,1.9155545329038195,5.273810792524387,"['ATP5PB', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.548671726038287,0,0,9
42,Nanomaterial induced apoptosis WP2507,0.06865023983183353,3.752188552188552,10.051102491445068,"['ENDOG', 'BAX', 'CYCS']",0.5769889204913629,0,0,3
43,DNA Replication WP466,0.073689627839679,2.448952649181482,6.386607021084281,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'UBA52']",0.6049404331955044,0,0,5
44,TCA cycle in senescence WP5050,0.08028248953178396,5.625126135216952,14.187714203917746,"['PDHA1', 'GOT1']",0.6309725611529259,0,0,2
45,Mitochondrial CII Assembly WP4920,0.08175506595876564,inf,inf,['SDHAF1'],0.6309725611529259,0,0,1
46,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.08333230853178267,2.3467020917678814,5.831364491930179,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.6309725611529259,0,0,5
47,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.08401051097503545,3.3766666666666665,8.363373103189602,"['LDHA', 'PDHA1', 'RPS6']",0.6309725611529259,0,0,3
48,Type 2 papillary renal cell carcinoma WP4241,0.09984667693749849,2.501966071227952,5.764828813605035,"['SETD2', 'ELOB', 'ELOC', 'RBX1']",0.7193036114068768,0,0,4
49,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.09984667693749849,2.501966071227952,5.764828813605035,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.7193036114068768,0,0,4
50,HIF1A and PPARG regulation of glycolysis WP2456,0.10645819688651864,4.499697275479313,10.07933489393309,"['LDHA', 'TPI1']",0.7515948700188215,0,0,2
51,Copper homeostasis WP3286,0.11597402203401794,2.085395111710901,4.4927524164045245,"['CCND1', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.8027221525099674,0,0,5
52,TP53 network WP1742,0.13747503282999401,2.596736596736597,5.152738076849278,"['SUMO1', 'GADD45A', 'BAX']",0.9332439728651517,0,0,3
53,Sleep regulation WP3591,0.1428891945394399,2.143964562569214,4.171481431774855,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9516959560834394,0,0,4
54,miRNA Biogenesis WP2338,0.15683253395390603,11.241935483870968,20.826547803697178,['RAN'],0.9808513775422545,0,0,1
55,Non-small cell lung cancer WP4255,0.15833451839420548,1.7323669238562855,3.1928306805933295,"['CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.9808513775422545,0,0,6
56,Alzheimer's disease WP2059,0.15962937168708344,1.6424737998647736,3.013776124346191,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9808513775422545,0,0,7
57,Cysteine and methionine catabolism WP4504,0.16393833222377624,3.213492864350584,5.810846497285278,"['AHCY', 'GOT1']",0.9808513775422545,0,0,2
58,Glycolysis in senescence WP5049,0.16393833222377624,3.213492864350584,5.810846497285278,"['LDHA', 'PGK1']",0.9808513775422545,0,0,2
59,Homologous recombination WP186,0.16393833222377624,3.213492864350584,5.810846497285278,"['POLD4', 'POLD2']",0.9808513775422545,0,0,2
60,NO/cGMP/PKG mediated Neuroprotection WP4008,0.17496087735779603,1.9571811667472634,3.411744290414835,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9999822974841958,0,0,4
61,Unfolded protein response WP4925,0.17802211260003475,2.25010101010101,3.8833312217413316,"['XBP1', 'DDIT3', 'EIF2S1']",0.9999822974841958,0,0,3
62,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.18277324788609206,1.6475646823337535,2.800050967860385,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9999822974841958,0,0,6
63,Metabolic reprogramming in colon cancer WP4290,0.19183942221751332,1.8754634310751601,3.0965712935368273,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9999822974841958,0,0,4
64,Myometrial relaxation and contraction pathways WP289,0.19284110391323964,1.3925261447630382,2.2919430808742702,"['PKIB', 'GNG3', 'YWHAQ', 'GSTO1', 'CRH', 'CALM3', 'ADCY2', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9999822974841958,0,0,11
65,Fatty acid transporters WP5061,0.194348761577736,2.8115539858728558,4.605609378459469,"['FABP3', 'FABP6']",0.9999822974841958,0,0,2
66,Canonical and non-canonical Notch signaling WP3845,0.19938710361403214,2.109280303030303,3.4012294634796616,"['RRAS', 'MFAP1', 'DLL3']",0.9999822974841958,0,0,3
67,Gastric Cancer Network 2 WP2363,0.22131627751458358,1.9850267379679145,2.993742849121748,"['RFC3', 'S100A6', 'COL9A3']",0.9999822974841958,0,0,3
68,Serotonin and anxiety WP3947,0.22537896265666096,2.498934858167956,3.7233430062531716,"['POMC', 'CRH']",0.9999822974841958,0,0,2
69,Galanin receptor pathway WP4970,0.22537896265666096,2.498934858167956,3.7233430062531716,"['POMC', 'VAMP2']",0.9999822974841958,0,0,2
70,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.22537896265666096,2.498934858167956,3.7233430062531716,"['BAD', 'BAX']",0.9999822974841958,0,0,2
71,RalA downstream regulated genes WP2290,0.22537896265666096,2.498934858167956,3.7233430062531716,"['RAC3', 'HRAS']",0.9999822974841958,0,0,2
72,MED and Pseudoachondroplasia genes WP4789,0.2257772146191461,5.620463709677419,8.364410861411177,['COL9A3'],0.9999822974841958,0,0,1
73,Proximal tubule transport WP4917,0.2258674762268768,1.6075766338924233,2.3917635118569747,"['ATP6V1G1', 'ATP6V1E1', 'SLC6A20', 'ATP6V1D', 'ATP6V1F']",0.9999822974841958,0,0,5
74,Endometrial cancer WP4155,0.24136975076001058,1.562781151596941,2.2213766449103556,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'HRAS']",0.9999822974841958,0,0,5
75,IL-18 signaling pathway WP4754,0.2424780138197972,1.2432710973070271,1.7615214897149984,"['NRN1', 'TOMM40', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'ITM2C']",0.9999822974841958,0,0,16
76,Nucleotide metabolism WP404,0.25672470994643287,2.2488395560040364,3.057861690561699,"['NME2', 'OAZ1']",0.9999822974841958,0,0,2
77,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.26359158606768196,1.436461230032982,1.915311896008863,"['CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9999822974841958,0,0,6
78,GABA receptor Signaling WP4159,0.26640527761977584,1.7757575757575759,2.348859413216593,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9999822974841958,0,0,3
79,MET in type 1 papillary renal cell carcinoma WP4205,0.2822798240732817,1.5514103413409575,1.962311324224951,"['BAD', 'RPL11', 'HRAS', 'PAK4']",0.9999822974841958,0,0,4
80,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.28812729126597725,2.0442161269608294,2.543726292241647,"['CD63', 'SOD1']",0.9999822974841958,0,0,2
81,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.28812729126597725,2.0442161269608294,2.543726292241647,"['RRAS', 'HRAS']",0.9999822974841958,0,0,2
82,Acetylcholine Synthesis WP528,0.28908959188317823,3.7466397849462365,4.649649781992956,['PDHA1'],0.9999822974841958,0,0,1
83,The alternative pathway of fetal androgen synthesis WP4524,0.28908959188317823,3.7466397849462365,4.649649781992956,['STAR'],0.9999822974841958,0,0,1
84,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.28934898699305023,1.6868181818181818,2.0918599188454032,"['STAR', 'CALM3', 'CALM2']",0.9999822974841958,0,0,3
85,Bladder cancer WP2828,0.3124257182033239,1.6063492063492064,1.868808257600492,"['CCND1', 'DAPK1', 'HRAS']",0.9999822974841958,0,0,3
86,Intraflagellar transport proteins binding to dynein WP4532,0.319368111306647,1.8736966027581567,2.138657702355565,"['IFT22', 'DYNLL1']",0.9999822974841958,0,0,2
87,Methionine De Novo and Salvage Pathway WP3580,0.319368111306647,1.8736966027581567,2.138657702355565,"['AHCY', 'TXN']",0.9999822974841958,0,0,2
88,Kit receptor signaling pathway WP304,0.32019224114795086,1.4510584167781075,1.6525142401788813,"['BAD', 'RPS6', 'KIT', 'HRAS']",0.9999822974841958,0,0,4
89,G Protein Signaling Pathways WP35,0.3217659691935633,1.3233208176887776,1.50055423535655,"['GNG10', 'GNG3', 'RRAS', 'ADCY2', 'HRAS', 'CALM2']",0.9999822974841958,0,0,6
90,DNA damage response WP707,0.32226401411334427,1.3715809222869557,1.5531564965404783,"['CCND1', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.9999822974841958,0,0,5
91,CAMKK2  Pathway WP4874,0.33554433152233615,1.5331955922865015,1.6742514198877345,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9999822974841958,0,0,3
92,miRNA regulation of DNA damage response WP1530,0.3388700548825507,1.3388037401195296,1.4487711568344692,"['CCND1', 'GADD45A', 'RPA2', 'CYCS', 'BAX']",0.9999822974841958,0,0,5
93,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.3472293559379973,2.809727822580645,2.972045094372866,['MAP1LC3A'],0.9999822974841958,0,0,1
94,Iron metabolism in placenta WP2007,0.3472293559379973,2.809727822580645,2.972045094372866,['FTH1'],0.9999822974841958,0,0,1
95,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3472293559379973,2.809727822580645,2.972045094372866,['MOCS2'],0.9999822974841958,0,0,1
96,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3502638716711036,1.7294108515097415,1.814270429705429,"['GOT1', 'SCO2']",0.9999822974841958,0,0,2
97,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3502638716711036,1.7294108515097415,1.814270429705429,"['LDHA', 'PDHA1']",0.9999822974841958,0,0,2
98,Acute viral myocarditis WP4298,0.35553865702526544,1.307551078052914,1.3521664151299457,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX']",0.9999822974841958,0,0,5
99,IL-7 signaling pathway WP205,0.38066226996369956,1.6057373504396713,1.5508897422113859,"['CCND1', 'BAD']",0.9999822974841958,0,0,2
100,Pancreatic adenocarcinoma pathway WP4263,0.38152055020362413,1.2266371925946393,1.1819760228341838,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'PAK4']",0.9999822974841958,0,0,6
101,Oxidative Damage WP3941,0.38157830516681646,1.4051767676767677,1.3538023715117957,"['BAD', 'GADD45A', 'CYCS']",0.9999822974841958,0,0,3
102,Leptin signaling pathway WP2034,0.38893574871409714,1.249212775528565,1.1796829908196733,"['CCND1', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9999822974841958,0,0,5
103,Genotoxicity pathway WP4286,0.39664968350075314,1.2847609417882422,1.1880207517992822,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9999822974841958,0,0,4
104,Modulators of TCR signaling and T cell activation WP5072,0.39664968350075314,1.2847609417882422,1.1880207517992822,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9999822974841958,0,0,4
105,Alanine and aspartate metabolism WP106,0.4006187157466998,2.2475806451612903,2.0559634664215776,['GOT1'],0.9999822974841958,0,0,1
106,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4006187157466998,2.2475806451612903,2.0559634664215776,['DLL3'],0.9999822974841958,0,0,1
107,Thiamine metabolic pathways WP4297,0.4006187157466998,2.2475806451612903,2.0559634664215776,['PDHA1'],0.9999822974841958,0,0,1
108,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4006187157466998,2.2475806451612903,2.0559634664215776,['VIP'],0.9999822974841958,0,0,1
109,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4006187157466998,2.2475806451612903,2.0559634664215776,['RPS6'],0.9999822974841958,0,0,1
110,Insulin signaling in adipocytes (normal condition) WP3634,0.4006187157466998,2.2475806451612903,2.0559634664215776,['RPS6'],0.9999822974841958,0,0,1
111,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4006187157466998,2.2475806451612903,2.0559634664215776,['AHCY'],0.9999822974841958,0,0,1
112,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4006187157466998,2.2475806451612903,2.0559634664215776,['VEGFB'],0.9999822974841958,0,0,1
113,Imatinib and Chronic Myeloid Leukemia WP3640,0.4104381650694866,1.498553649512277,1.3345069734688735,"['GADD45A', 'KIT']",0.9999822974841958,0,0,2
114,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4104381650694866,1.498553649512277,1.3345069734688735,"['BAD', 'HRAS']",0.9999822974841958,0,0,2
115,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4156254784084724,1.2489607909223683,1.0965510005048809,"['RPS6', 'ADCY2', 'HRAS', 'MYL12B']",0.9999822974841958,0,0,4
116,16p11.2 proximal deletion syndrome WP4949,0.4222122480939198,1.1958394349211818,1.0311091252677544,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999822974841958,0,0,5
117,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4268638493742682,1.2968531468531468,1.1039983365274686,"['ADCY2', 'BANF1', 'HRAS']",0.9999822974841958,0,0,3
118,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4268638493742682,1.2968531468531468,1.1039983365274686,"['YWHAQ', 'ACTG1', 'PAK4']",0.9999822974841958,0,0,3
119,Senescence and Autophagy in Cancer WP615,0.44136699089586456,1.1430632115810624,0.9348869057099407,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9999822974841958,0,0,6
120,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.4496454506280491,1.8728158602150538,1.496934027770173,['HMGCS1'],0.9999822974841958,0,0,1
121,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4496454506280491,1.8728158602150538,1.496934027770173,['IDH3B'],0.9999822974841958,0,0,1
122,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.4496454506280491,1.8728158602150538,1.496934027770173,['NSDHL'],0.9999822974841958,0,0,1
123,NOTCH1 regulation of endothelial cell calcification WP3413,0.4496454506280491,1.8728158602150538,1.496934027770173,['DLL3'],0.9999822974841958,0,0,1
124,Purine metabolism WP4792,0.4496454506280491,1.8728158602150538,1.496934027770173,['APRT'],0.9999822974841958,0,0,1
125,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4531289799885411,1.1830131445904954,0.9364477349715652,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9999822974841958,0,0,4
126,Cell cycle WP179,0.4566787952329771,1.1081050195697513,0.868505000938543,"['CDKN2D', 'CCND1', 'YWHAQ', 'GADD45A', 'RBX1', 'ANAPC11', 'YWHAH']",0.9999822974841958,0,0,7
127,Glycosylation and related congenital defects WP4521,0.4677375676770437,1.322015789161275,1.0045309121342956,"['DPM2', 'DPM3']",0.9999822974841958,0,0,2
128,Ras signaling WP4223,0.46780004167904504,1.0703870561449402,0.8131883913397784,"['GNG10', 'GNG3', 'RRAS', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'PAK4']",0.9999822974841958,0,0,10
129,Pathways in clear cell renal cell carcinoma WP4018,0.47090774786242867,1.1053864168618266,0.832458848619721,"['SETD2', 'LDHA', 'TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.9999822974841958,0,0,6
130,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.48980873165074224,1.12366026289181,0.8020016217318973,"['PSMD8', 'PSMC5', 'PSMD7', 'STUB1']",0.9999822974841958,0,0,4
131,IL-3 signaling pathway WP286,0.4923726177869957,1.1623824451410658,0.823570624087681,"['YWHAQ', 'BAD', 'HRAS']",0.9999822974841958,0,0,3
132,Serotonin and anxiety-related events WP3944,0.49466571478043625,1.605126728110599,1.1298054750020838,['CRH'],0.9999822974841958,0,0,1
133,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.49466571478043625,1.605126728110599,1.1298054750020838,['PDHA1'],0.9999822974841958,0,0,1
134,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.49466571478043625,1.605126728110599,1.1298054750020838,['CCK'],0.9999822974841958,0,0,1
135,Dopamine metabolism WP2436,0.49466571478043625,1.605126728110599,1.1298054750020838,['SOD1'],0.9999822974841958,0,0,1
136,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.49511769793804306,1.2484583473483575,0.8776159940360694,"['MAP1LC3A', 'FTL']",0.9999822974841958,0,0,2
137,Oxidative Stress WP408,0.49511769793804306,1.2484583473483575,0.8776159940360694,"['TXN2', 'SOD1']",0.9999822974841958,0,0,2
138,SARS-CoV-2 mitochondrial interactions WP5038,0.49511769793804306,1.2484583473483575,0.8776159940360694,"['NDUFB9', 'PHB']",0.9999822974841958,0,0,2
139,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5133818865511667,1.1235353535353536,0.7491006726013374,"['BEX3', 'SERBP1', 'RNF7']",0.9999822974841958,0,0,3
140,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5133818865511667,1.1235353535353536,0.7491006726013374,"['RRAS', 'CHP1', 'CALM2']",0.9999822974841958,0,0,3
141,Cytosolic DNA-sensing pathway WP4655,0.5133818865511667,1.1235353535353536,0.7491006726013374,"['POLR3K', 'POLR2K', 'POLR2L']",0.9999822974841958,0,0,3
142,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5215834686828591,1.182643794147326,0.769766244068539,"['RAB3A', 'NEFL']",0.9999822974841958,0,0,2
143,Parkinson's disease pathway WP2371,0.5215834686828591,1.182643794147326,0.769766244068539,"['CYCS', 'PARK7']",0.9999822974841958,0,0,2
144,G1 to S cell cycle control WP45,0.5254320738139749,1.069960036592999,0.6885560442999773,"['CDKN2D', 'CCND1', 'GADD45A', 'RPA2']",0.9999822974841958,0,0,4
145,Biomarkers for urea cycle disorders WP4583,0.5360066138793129,1.404359879032258,0.875771148962956,['GOT1'],0.9999822974841958,0,0,1
146,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5360066138793129,1.404359879032258,0.875771148962956,['CCND1'],0.9999822974841958,0,0,1
147,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5360066138793129,1.404359879032258,0.875771148962956,['ADCY2'],0.9999822974841958,0,0,1
148,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5360066138793129,1.404359879032258,0.875771148962956,['BAX'],0.9999822974841958,0,0,1
149,Nanoparticle triggered autophagic cell death WP2509,0.5360066138793129,1.404359879032258,0.875771148962956,['MAP1LC3A'],0.9999822974841958,0,0,1
150,Nanoparticle triggered regulated necrosis WP2513,0.5360066138793129,1.404359879032258,0.875771148962956,['FTL'],0.9999822974841958,0,0,1
151,Integrated breast cancer pathway WP1984,0.5364214011794172,1.0212059745528306,0.6360430586215515,"['CCND1', 'RRAS', 'GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9999822974841958,0,0,7
152,MAPK Cascade WP422,0.5471012726319391,1.1234106962663977,0.6775529777292237,"['RRAS', 'HRAS']",0.9999822974841958,0,0,2
153,Rett syndrome causing genes WP4312,0.5471012726319391,1.1234106962663977,0.6775529777292237,"['EIF2B2', 'GPS2']",0.9999822974841958,0,0,2
154,Exercise-induced Circadian Regulation WP410,0.5539555608736736,1.053125,0.6220501972885624,"['IDI1', 'SUMO1', 'STBD1']",0.9999822974841958,0,0,3
155,Notch Signaling Pathway Netpath WP61,0.5539555608736736,1.053125,0.6220501972885624,"['PSENEN', 'CCND1', 'DLL3']",0.9999822974841958,0,0,3
156,22q11.2 copy number variation syndrome WP4657,0.5650904454715376,1.0028376229034124,0.572389108716101,"['RANBP1', 'MRPL40', 'RAN', 'RBX1', 'PAK4']",0.9999822974841958,0,0,5
157,Aryl Hydrocarbon Receptor Pathway WP2873,0.5716490933534257,1.0698188458027005,0.5982747385906838,"['AIP', 'BAX']",0.9999822974841958,0,0,2
158,Vitamin D-sensitive calcium signaling in depression WP4698,0.5716490933534257,1.0698188458027005,0.5982747385906838,"['GPX4', 'PVALB']",0.9999822974841958,0,0,2
159,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5716490933534257,1.0698188458027005,0.5982747385906838,"['MAP1LC3A', 'EIF2B2']",0.9999822974841958,0,0,2
160,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5716490933534257,1.0698188458027005,0.5982747385906838,"['CYCS', 'ACTG1']",0.9999822974841958,0,0,2
161,IL-2 signaling pathway WP49,0.5716490933534257,1.0698188458027005,0.5982747385906838,"['RPS6', 'HRAS']",0.9999822974841958,0,0,2
162,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5739685721352716,1.2482078853046594,0.6929808482965801,['STAR'],0.9999822974841958,0,0,1
163,ERK Pathway in Huntington's Disease WP3853,0.5739685721352716,1.2482078853046594,0.6929808482965801,['HRAS'],0.9999822974841958,0,0,1
164,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5739685721352716,1.2482078853046594,0.6929808482965801,['CCND1'],0.9999822974841958,0,0,1
165,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5739685721352716,1.2482078853046594,0.6929808482965801,['RRAS'],0.9999822974841958,0,0,1
166,Osteoclast Signaling WP12,0.5739685721352716,1.2482078853046594,0.6929808482965801,['ATP6V1G1'],0.9999822974841958,0,0,1
167,Overview of nanoparticle effects WP3287,0.5739685721352716,1.2482078853046594,0.6929808482965801,['BAX'],0.9999822974841958,0,0,1
168,PPAR-alpha pathway WP2878,0.5739685721352716,1.2482078853046594,0.6929808482965801,['CCND1'],0.9999822974841958,0,0,1
169,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5739685721352716,1.2482078853046594,0.6929808482965801,['ANAPC11'],0.9999822974841958,0,0,1
170,Thermogenesis WP4321,0.5764822315792453,0.9983597348612515,0.5499072852569655,"['RPS6', 'ADCY2', 'HRAS', 'ACTG1']",0.9999822974841958,0,0,4
171,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5924424062770094,0.9909982174688057,0.5187891675976893,"['IDI1', 'SQLE', 'HMGCS1']",0.9999822974841958,0,0,3
172,p53 transcriptional gene network WP4963,0.5924424062770094,0.9909982174688057,0.5187891675976893,"['SIVA1', 'GADD45A', 'BAX']",0.9999822974841958,0,0,3
173,Glycogen Synthesis and Degradation WP500,0.595214837960577,1.021098981744794,0.5297797115816103,"['CALM3', 'CALM2']",0.9999822974841958,0,0,2
174,Histone Modifications WP2369,0.595214837960577,1.021098981744794,0.5297797115816103,"['SETD2', 'SET']",0.9999822974841958,0,0,2
175,miRNA regulation of prostate cancer signaling pathways WP3981,0.595214837960577,1.021098981744794,0.5297797115816103,"['CCND1', 'BAD']",0.9999822974841958,0,0,2
176,p38 MAPK Signaling Pathway WP400,0.595214837960577,1.021098981744794,0.5297797115816103,"['DDIT3', 'HRAS']",0.9999822974841958,0,0,2
177,PDGF Pathway WP2526,0.595214837960577,1.021098981744794,0.5297797115816103,"['ARFIP2', 'HRAS']",0.9999822974841958,0,0,2
178,Transcriptional cascade regulating adipogenesis WP4211,0.6088275065494078,1.1232862903225806,0.5573974508369496,['DDIT3'],0.9999822974841958,0,0,1
179,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6088275065494078,1.1232862903225806,0.5573974508369496,['CCND1'],0.9999822974841958,0,0,1
180,Genes targeted by miRNAs in adipocytes WP1992,0.6088275065494078,1.1232862903225806,0.5573974508369496,['TMSB4X'],0.9999822974841958,0,0,1
181,Hedgehog Signaling Pathway Netpath WP47,0.6088275065494078,1.1232862903225806,0.5573974508369496,['SAP18'],0.9999822974841958,0,0,1
182,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6088275065494078,1.1232862903225806,0.5573974508369496,['CCND1'],0.9999822974841958,0,0,1
183,Purine metabolism and related disorders WP4224,0.6088275065494078,1.1232862903225806,0.5573974508369496,['APRT'],0.9999822974841958,0,0,1
184,Endothelin Pathways WP2197,0.6177948645683973,0.9766156276049665,0.4703369250411796,"['RIIAD1', 'CALM2']",0.9999822974841958,0,0,2
185,Small cell lung cancer WP4658,0.6225583293917343,0.935644399460189,0.4434186787141921,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'CKS1B']",0.9999822974841958,0,0,5
186,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6242638428530121,0.9357094708459723,0.44088962354126826,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9999822974841958,0,0,4
187,ErbB signaling pathway WP673,0.6242638428530121,0.9357094708459723,0.44088962354126826,"['CCND1', 'BAD', 'HRAS', 'PAK4']",0.9999822974841958,0,0,4
188,Calcium Regulation in the Cardiac Cell WP536,0.6347621816340364,0.9257208645141033,0.42074463872933926,"['PKIB', 'GNG3', 'YWHAQ', 'CALM3', 'ADCY2', 'CALR', 'CALM2', 'YWHAH']",0.9999822974841958,0,0,8
189,TGF-beta Signaling Pathway WP366,0.6347818380229044,0.9226797684973144,0.4193338740295005,"['PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'RBX1']",0.9999822974841958,0,0,6
190,Cardiac Progenitor Differentiation WP2406,0.6393926836741654,0.9358392196434577,0.4185414430326753,"['MESP1', 'KIT']",0.9999822974841958,0,0,2
191,Common Pathways Underlying Drug Addiction WP2636,0.6393926836741654,0.9358392196434577,0.4185414430326753,"['CALM2', 'ACTG1']",0.9999822974841958,0,0,2
192,Retinoblastoma gene in cancer WP2446,0.6394090242107003,0.9165308185963971,0.4098825987456726,"['RFC3', 'CCND1', 'H2AFZ', 'RPA2']",0.9999822974841958,0,0,4
193,Apoptosis Modulation by HSP70 WP384,0.6408368242742009,1.0210777126099706,0.45435958816745975,['CYCS'],0.9999822974841958,0,0,1
194,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6408368242742009,1.0210777126099706,0.45435958816745975,['CCND1'],0.9999822974841958,0,0,1
195,Glutathione metabolism WP100,0.6408368242742009,1.0210777126099706,0.45435958816745975,['GPX4'],0.9999822974841958,0,0,1
196,Glycerolipids and Glycerophospholipids WP4722,0.6408368242742009,1.0210777126099706,0.45435958816745975,['CDIPT'],0.9999822974841958,0,0,1
197,Glycerophospholipid Biosynthetic Pathway WP2533,0.6408368242742009,1.0210777126099706,0.45435958816745975,['CDIPT'],0.9999822974841958,0,0,1
198,Folate Metabolism WP176,0.6459875117995237,0.9104013104013104,0.3978227099946695,"['AHCY', 'GPX4', 'SOD1']",0.9999822974841958,0,0,3
199,Pathogenic Escherichia coli infection WP2272,0.6459875117995237,0.9104013104013104,0.3978227099946695,"['YWHAQ', 'ARPC5L', 'ACTG1']",0.9999822974841958,0,0,3
200,Prader-Willi and Angelman Syndrome WP3998,0.6459875117995237,0.9104013104013104,0.3978227099946695,"['POMC', 'CCND1', 'FEZ1']",0.9999822974841958,0,0,3
201,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6570091471028034,0.9030099554685133,0.37931595813898017,"['YWHAQ', 'TAC1', 'ALDOA', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9999822974841958,0,0,7
202,Hippo-Merlin Signaling Dysregulation WP4541,0.6590321446026225,0.8979128672745694,0.37441437223994345,"['CCND1', 'KIT', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9999822974841958,0,0,6
203,Aryl Hydrocarbon Receptor Netpath WP2586,0.660017815343612,0.8983249243188698,0.3732436316422929,"['AIP', 'HRAS']",0.9999822974841958,0,0,2
204,Interleukin-11 Signaling Pathway WP2332,0.660017815343612,0.8983249243188698,0.3732436316422929,"['RPS6', 'HRAS']",0.9999822974841958,0,0,2
205,Airway smooth muscle cell contraction WP4962,0.6702292570792552,0.9359038978494624,0.3744883276787623,['CALM2'],0.9999822974841958,0,0,1
206,miRNAs involved in DNA damage response WP1545,0.6702292570792552,0.9359038978494624,0.3744883276787623,['CCND1'],0.9999822974841958,0,0,1
207,MTHFR deficiency WP4288,0.6702292570792552,0.9359038978494624,0.3744883276787623,['CYCS'],0.9999822974841958,0,0,1
208,Nicotine Activity on Dopaminergic Neurons WP1602,0.6702292570792552,0.9359038978494624,0.3744883276787623,['ADCY2'],0.9999822974841958,0,0,1
209,IL-6 signaling pathway WP364,0.6796847847625768,0.8636963440192502,0.3334957355390257,"['BAD', 'VIP']",0.9999822974841958,0,0,2
210,Integrated Cancer Pathway WP1971,0.6796847847625768,0.8636963440192502,0.3334957355390257,"['BAD', 'BAX']",0.9999822974841958,0,0,2
211,Circadian rhythm related genes WP3594,0.6863614256809646,0.8799442619687469,0.33116784169629854,"['KDM5A', 'AHCY', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'HCRTR1']",0.9999822974841958,0,0,8
212,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6972185472364979,0.863833746898263,0.3115471375900501,['HRAS'],0.9999822974841958,0,0,1
213,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6972185472364979,0.863833746898263,0.3115471375900501,['CALM2'],0.9999822974841958,0,0,1
214,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6972185472364979,0.863833746898263,0.3115471375900501,['BAX'],0.9999822974841958,0,0,1
215,Apoptosis Modulation and Signaling WP1772,0.7113989433805947,0.8373617741253248,0.28514002627871887,"['ENDOG', 'AIFM2', 'BAD', 'CYCS', 'BAX']",0.9999822974841958,0,0,5
216,DNA damage response (only ATM dependent) WP710,0.7113989433805947,0.8373617741253248,0.28514002627871887,"['CCND1', 'BAD', 'RAC3', 'BAX', 'HRAS']",0.9999822974841958,0,0,5
217,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7151104139005304,0.8414133738601823,0.2821413216195977,"['RAB3A', 'BAD', 'RPS6', 'RACK1', 'EIF2S1', 'HRAS']",0.9999822974841958,0,0,6
218,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7162221912259252,0.8018595934842151,0.2676325366929232,"['STAR', 'HRAS']",0.9999822974841958,0,0,2
219,One-carbon metabolism and related pathways WP3940,0.7162221912259252,0.8018595934842151,0.2676325366929232,"['GPX4', 'SOD1']",0.9999822974841958,0,0,2
220,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7162221912259252,0.8018595934842151,0.2676325366929232,"['CCND1', 'BAX']",0.9999822974841958,0,0,2
221,TNF-alpha signaling pathway WP231,0.7216624918329023,0.8161044213622576,0.26621139518053794,"['BAD', 'BAX', 'TXN', 'HRAS']",0.9999822974841958,0,0,4
222,Blood Clotting Cascade WP272,0.7220009947061017,0.802059331797235,0.26125379350242733,['F8A1'],0.9999822974841958,0,0,1
223,Fatty acid beta-oxidation WP143,0.7220009947061017,0.802059331797235,0.26125379350242733,['TPI1'],0.9999822974841958,0,0,1
224,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7220009947061017,0.802059331797235,0.26125379350242733,['H2AFZ'],0.9999822974841958,0,0,1
225,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7220009947061017,0.802059331797235,0.26125379350242733,['RPS6'],0.9999822974841958,0,0,1
226,Physiological and pathological hypertrophy of the heart WP1528,0.7220009947061017,0.802059331797235,0.26125379350242733,['CALM2'],0.9999822974841958,0,0,1
227,PPAR signaling pathway WP3942,0.7331393199436623,0.7741396708305787,0.2403080704667863,"['FABP3', 'FABP6']",0.9999822974841958,0,0,2
228,Gastrin signaling pathway WP4659,0.7338761184236423,0.8129437305638678,0.25153701739913753,"['CCND1', 'BAD', 'RPS6', 'KIT', 'HRAS']",0.9999822974841958,0,0,5
229,Amino Acid metabolism WP3925,0.7375439325999413,0.7829457364341085,0.23835187530579538,"['LDHA', 'PDHA1', 'GOT1']",0.9999822974841958,0,0,3
230,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7375439325999413,0.7829457364341085,0.23835187530579538,"['BAD', 'BAX', 'HRAS']",0.9999822974841958,0,0,3
231,Striated Muscle Contraction Pathway WP383,0.7447568799519072,0.7485215053763441,0.22058737852781057,['ACTG1'],0.9999822974841958,0,0,1
232,Urea cycle and associated pathways WP4595,0.7447568799519072,0.7485215053763441,0.22058737852781057,['GOT1'],0.9999822974841958,0,0,1
233,Hippo-Yap signaling pathway WP4537,0.7447568799519072,0.7485215053763441,0.22058737852781057,['YWHAQ'],0.9999822974841958,0,0,1
234,Nanoparticle-mediated activation of receptor signaling WP2643,0.7447568799519072,0.7485215053763441,0.22058737852781057,['HRAS'],0.9999822974841958,0,0,1
235,NRF2-ARE regulation WP4357,0.7447568799519072,0.7485215053763441,0.22058737852781057,['RBX1'],0.9999822974841958,0,0,1
236,PDGFR-beta pathway WP3972,0.7447568799519072,0.7485215053763441,0.22058737852781057,['HRAS'],0.9999822974841958,0,0,1
237,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7447568799519072,0.7485215053763441,0.22058737852781057,['BAX'],0.9999822974841958,0,0,1
238,Regulation of Actin Cytoskeleton WP51,0.7455485038345552,0.8107811183945508,0.2380737824065703,"['RRAS', 'TMSB4X', 'BRK1', 'RAC3', 'ACTG1', 'PAK4']",0.9999822974841958,0,0,6
239,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7491904127432842,0.748267743020518,0.21607136869254304,"['NDUFA13', 'COPS6']",0.9999822974841958,0,0,2
240,Interferon type I signaling pathways WP585,0.7644038451033933,0.7240649718433645,0.1945265976296544,"['RPS6', 'RACK1']",0.9999822974841958,0,0,2
241,Statin inhibition of cholesterol production WP430,0.7656517695802508,0.7016759072580645,0.1873669889215727,['SQLE'],0.9999822974841958,0,0,1
242,Autophagy WP4923,0.7656517695802508,0.7016759072580645,0.1873669889215727,['MAP1LC3B'],0.9999822974841958,0,0,1
243,Pregnane X receptor pathway WP2876,0.7656517695802508,0.7016759072580645,0.1873669889215727,['PSMC5'],0.9999822974841958,0,0,1
244,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7656517695802508,0.7016759072580645,0.1873669889215727,['HRAS'],0.9999822974841958,0,0,1
245,Complement system WP2806,0.7682481080308882,0.7605011053795137,0.20050044360791652,"['RPS19', 'CD59', 'TXN', 'CALR']",0.9999822974841958,0,0,4
246,Integrin-mediated Cell Adhesion WP185,0.7788899315278419,0.7477586788001348,0.18685407949724125,"['RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9999822974841958,0,0,4
247,Ethanol effects on histone modifications WP3996,0.7848377161830535,0.6603415559772297,0.15998643854817174,['AHCY'],0.9999822974841958,0,0,1
248,Head and Neck Squamous Cell Carcinoma WP4674,0.7874362836882841,0.7160541586073501,0.171117482384235,"['CCND1', 'RPS6', 'HRAS']",0.9999822974841958,0,0,3
249,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8024543605467955,0.6235999103942652,0.13724205360597672,['HRAS'],0.9999822974841958,0,0,1
250,Trans-sulfuration and one-carbon metabolism WP2525,0.8024543605467955,0.6235999103942652,0.13724205360597672,['AHCY'],0.9999822974841958,0,0,1
251,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8024543605467955,0.6235999103942652,0.13724205360597672,['DDIT3'],0.9999822974841958,0,0,1
252,One-carbon metabolism WP241,0.8024543605467955,0.6235999103942652,0.13724205360597672,['AHCY'],0.9999822974841958,0,0,1
253,Pathways affected in adenoid cystic carcinoma WP3651,0.8174812448128036,0.6410840420931239,0.12919594799958062,"['SETD2', 'HRAS']",0.9999822974841958,0,0,2
254,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8186299436852574,0.5907258064516129,0.11821790116982256,['PPIB'],0.9999822974841958,0,0,1
255,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8186299436852574,0.5907258064516129,0.11821790116982256,['SUPT4H1'],0.9999822974841958,0,0,1
256,Lipid Metabolism Pathway WP3965,0.8186299436852574,0.5907258064516129,0.11821790116982256,['PDHA1'],0.9999822974841958,0,0,1
257,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8186299436852574,0.5907258064516129,0.11821790116982256,['OMG'],0.9999822974841958,0,0,1
258,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8186299436852574,0.5907258064516129,0.11821790116982256,['CCND1'],0.9999822974841958,0,0,1
259,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8186299436852574,0.5907258064516129,0.11821790116982256,['BAX'],0.9999822974841958,0,0,1
260,Corticotropin-releasing hormone signaling pathway WP2355,0.819472171684097,0.6729090909090909,0.13397272715072986,"['POMC', 'STAR', 'CRH']",0.9999822974841958,0,0,3
261,Breast cancer pathway WP4262,0.8298472280389075,0.7229466941203386,0.13483943226912581,"['CCND1', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'DLL3']",0.9999822974841958,0,0,6
262,Target Of Rapamycin (TOR) Signaling WP1471,0.8334822366402269,0.5611391129032258,0.10220749903599521,['IDI1'],0.9999822974841958,0,0,1
263,The influence of laminopathies on Wnt signaling WP4844,0.8334822366402269,0.5611391129032258,0.10220749903599521,['CCND1'],0.9999822974841958,0,0,1
264,White fat cell differentiation WP4149,0.8334822366402269,0.5611391129032258,0.10220749903599521,['DDIT3'],0.9999822974841958,0,0,1
265,Melatonin metabolism and effects WP3298,0.8334822366402269,0.5611391129032258,0.10220749903599521,['CALM2'],0.9999822974841958,0,0,1
266,Focal Adhesion WP306,0.8377717972043873,0.740495867768595,0.1310748284510162,"['CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9999822974841958,0,0,8
267,BDNF-TrkB Signaling WP3676,0.8471193945487936,0.5343701996927803,0.08865930097211862,['HRAS'],0.9999822974841958,0,0,1
268,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8471193945487936,0.5343701996927803,0.08865930097211862,['HRAS'],0.9999822974841958,0,0,1
269,Prion disease pathway WP3995,0.8471193945487936,0.5343701996927803,0.08865930097211862,['HSP90B1'],0.9999822974841958,0,0,1
270,Prolactin Signaling Pathway WP2037,0.8473031040089277,0.6346483704974271,0.10515919927585737,"['RPS6', 'PPIB', 'HRAS']",0.9999822974841958,0,0,3
271,Hepatitis B infection WP4666,0.8493626892672899,0.6832600967710082,0.1115551845774657,"['YWHAQ', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9999822974841958,0,0,5
272,3q29 copy number variation syndrome WP4906,0.8499843180229388,0.5903128153380424,0.0959478978262923,"['NCBP2', 'DYNLL1']",0.9999822974841958,0,0,2
273,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8595893006511207,0.5751248415224197,0.08701671127311217,"['HMGCS1', 'CALM2']",0.9999822974841958,0,0,2
274,Endochondral Ossification WP474,0.8595893006511207,0.5751248415224197,0.08701671127311217,"['HMGCS1', 'CALM2']",0.9999822974841958,0,0,2
275,Oncostatin M Signaling Pathway WP2374,0.8595893006511207,0.5751248415224197,0.08701671127311217,"['RPS6', 'HRAS']",0.9999822974841958,0,0,2
276,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8596407409875304,0.5100348240469208,0.0771380340400788,['CCND1'],0.9999822974841958,0,0,1
277,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8596407409875304,0.5100348240469208,0.0771380340400788,['CCND1'],0.9999822974841958,0,0,1
278,Apoptosis WP254,0.8637172911920907,0.6114600550964188,0.08958487386531902,"['BAD', 'CYCS', 'BAX']",0.9999822974841958,0,0,3
279,Heart Development WP1591,0.8711374885381838,0.4878155680224404,0.0672968226537751,['VEGFB'],0.9999822974841958,0,0,1
280,ATM Signaling Pathway WP2516,0.8816934004831908,0.4674479166666667,0.05885678878272397,['GADD45A'],0.9999822974841958,0,0,1
281,G13 Signaling Pathway WP524,0.8816934004831908,0.4674479166666667,0.05885678878272397,['CALM2'],0.9999822974841958,0,0,1
282,Differentiation Pathway WP2848,0.8913853984801707,0.44870967741935486,0.051591920342948204,['KIT'],0.9999822974841958,0,0,1
283,Hedgehog Signaling Pathway WP4249,0.8913853984801707,0.44870967741935486,0.051591920342948204,['CCND1'],0.9999822974841958,0,0,1
284,IL-5 signaling pathway WP127,0.8913853984801707,0.44870967741935486,0.051591920342948204,['RPS6'],0.9999822974841958,0,0,1
285,AGE/RAGE pathway WP2324,0.8926285234524528,0.5214371201276605,0.059227316312146484,"['CYCS', 'SOD1']",0.9999822974841958,0,0,2
286,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8926285234524528,0.5214371201276605,0.059227316312146484,"['IFI27L2', 'HRAS']",0.9999822974841958,0,0,2
287,Alpha 6 Beta 4 signaling pathway WP244,0.9002841211695053,0.431412841191067,0.04531770810105343,['HRAS'],0.9999822974841958,0,0,1
288,Neural Crest Cell Migration during Development WP4564,0.9002841211695053,0.431412841191067,0.04531770810105343,['PAK4'],0.9999822974841958,0,0,1
289,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9002841211695053,0.431412841191067,0.04531770810105343,['YWHAQ'],0.9999822974841958,0,0,1
290,Regulation of Microtubule Cytoskeleton WP2038,0.9002841211695053,0.431412841191067,0.04531770810105343,['PARD6A'],0.9999822974841958,0,0,1
291,Neovascularisation processes WP4331,0.9084544366645159,0.4153972520908005,0.039882516428317444,['KIT'],0.9999822974841958,0,0,1
292,Phosphoinositides metabolism WP4971,0.9084544366645159,0.4153972520908005,0.039882516428317444,['PIP4P1'],0.9999822974841958,0,0,1
293,EGF/EGFR signaling pathway WP437,0.9114059969884577,0.6018458055809499,0.05583132163435207,"['NDUFA13', 'AP2S1', 'NEDD8', 'HRAS', 'AP2M1']",0.9999822974841958,0,0,5
294,DNA IR-damage and cellular response via ATR WP4016,0.912499469654773,0.48729873206686264,0.044620860522119145,"['RPA2', 'EEF1E1']",0.9999822974841958,0,0,2
295,Insulin Signaling WP481,0.9157442163169969,0.5953893530881212,0.05240509506843787,"['XBP1', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9999822974841958,0,0,5
296,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9159559134537171,0.400525633640553,0.03516096177743708,['HRAS'],0.9999822974841958,0,0,1
297,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9159559134537171,0.400525633640553,0.03516096177743708,['CCND1'],0.9999822974841958,0,0,1
298,Neural Crest Cell Migration in Cancer WP4565,0.9159559134537171,0.400525633640553,0.03516096177743708,['PAK4'],0.9999822974841958,0,0,1
299,Prostaglandin Synthesis and Regulation WP98,0.9159559134537171,0.400525633640553,0.03516096177743708,['S100A6'],0.9999822974841958,0,0,1
300,Microglia Pathogen Phagocytosis Pathway WP3937,0.92284325328742,0.3866796440489433,0.031048783067034857,['RAC3'],0.9999822974841958,0,0,1
301,Chemokine signaling pathway WP3929,0.9249954385385848,0.5528467463081551,0.04310351080390898,"['GNG10', 'GNG3', 'ADCY2', 'HRAS']",0.9999822974841958,0,0,4
302,Glioblastoma signaling pathways WP2261,0.9288804291761578,0.4573405547890195,0.0337404172529827,"['CCND1', 'HRAS']",0.9999822974841958,0,0,2
303,Development of ureteric collection system WP5053,0.9291666881409094,0.37375672043010755,0.027458833108708447,['CCND1'],0.9999822974841958,0,0,1
304,Notch Signaling WP268,0.9291666881409094,0.37375672043010755,0.027458833108708447,['DLL3'],0.9999822974841958,0,0,1
305,Pre-implantation embryo WP3527,0.9291666881409094,0.37375672043010755,0.027458833108708447,['DDIT3'],0.9999822974841958,0,0,1
306,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9349723450625544,0.3616675338189386,0.02431792012267601,['RPS6'],0.9999822974841958,0,0,1
307,Wnt Signaling Pathway WP363,0.9349723450625544,0.3616675338189386,0.02431792012267601,['CCND1'],0.9999822974841958,0,0,1
308,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9349723450625544,0.3616675338189386,0.02431792012267601,['BAX'],0.9999822974841958,0,0,1
309,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9403025816109757,0.35033392137096775,0.021564300113761908,['RPS6'],0.9999822974841958,0,0,1
310,Vitamin B12 metabolism WP1533,0.9451962934288345,0.3396871945259042,0.019145672202121482,['SOD1'],0.9999822974841958,0,0,1
311,Phosphodiesterases in neuronal function WP4222,0.9451962934288345,0.3396871945259042,0.019145672202121482,['ADCY2'],0.9999822974841958,0,0,1
312,Mesodermal commitment pathway WP2857,0.9464168736771442,0.5144404541915089,0.028331335247565974,"['EPB41L5', 'SETD2', 'CCND1', 'RPL38']",0.9999822974841958,0,0,4
313,NRF2 pathway WP2884,0.9493878375323141,0.5085485798327052,0.026412936962350936,"['FTH1', 'TXN', 'SLC6A20', 'FTL']",0.9999822974841958,0,0,4
314,IL-4 signaling pathway WP395,0.9496891967582092,0.32966674573055027,0.01701756528870947,['BAD'],0.9999822974841958,0,0,1
315,Netrin-UNC5B signaling pathway WP4747,0.9496891967582092,0.32966674573055027,0.01701756528870947,['DAPK1'],0.9999822974841958,0,0,1
316,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9498364105987526,0.6272360464983369,0.03228102213606879,"['GNG10', 'GNG3', 'RAB14', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'ITGAE', 'HRAS', 'HSP90B1']",0.9999822974841958,0,0,10
317,TGF-beta Receptor Signaling WP560,0.9538140885035027,0.3202188940092166,0.01514203147034224,['HRAS'],0.9999822974841958,0,0,1
318,Cardiac Hypertrophic Response WP2795,0.9538140885035027,0.3202188940092166,0.01514203147034224,['CALM2'],0.9999822974841958,0,0,1
319,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9538140885035027,0.3202188940092166,0.01514203147034224,['PIN1'],0.9999822974841958,0,0,1
320,Adipogenesis WP236,0.9594737993531821,0.4475959595959596,0.018517165909682016,"['GADD45A', 'DDIT3', 'GTF3A']",0.9999822974841958,0,0,3
321,Endoderm differentiation WP2853,0.9594737993531821,0.4475959595959596,0.018517165909682016,"['EPB41L5', 'TCEAL2', 'NME1']",0.9999822974841958,0,0,3
322,Peptide GPCRs WP24,0.9610778374067268,0.30285527462946815,0.012023317160968293,['HCRTR1'],0.9999822974841958,0,0,1
323,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9642697403819664,0.29485887096774194,0.010728207033855816,['HRAS'],0.9999822974841958,0,0,1
324,Spinal Cord Injury WP2431,0.9643267321706824,0.4358913813459268,0.015833801507869505,"['CCND1', 'GADD45A', 'OMG']",0.9999822974841958,0,0,3
325,Vitamin D Receptor Pathway WP2877,0.9662967940037961,0.47077856420626896,0.016140290831948522,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6']",0.9999822974841958,0,0,4
326,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9698903532135899,0.2800655241935484,0.00856223372561493,['YWHAQ'],0.9999822974841958,0,0,1
327,Ectoderm Differentiation WP2858,0.9741722648764382,0.4091278640059128,0.01070570104475993,"['MAFB', 'KCNK10', 'LY6E']",0.9999822974841958,0,0,3
328,MECP2 and Associated Rett Syndrome WP3584,0.9746274921398581,0.26668106758832566,0.0068536875245050035,['RPS6'],0.9999822974841958,0,0,1
329,PI3K-Akt signaling pathway WP4172,0.9749322510512337,0.5746662331805644,0.01458922205021245,"['GNG10', 'GNG3', 'CCND1', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS', 'HSP90B1']",0.9999822974841958,0,0,10
330,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9814010810212902,0.3854406130268199,0.0072362828124451235,"['STRAP', 'HRAS', 'DLL3']",0.9999822974841958,0,0,3
331,Fragile X Syndrome  WP4549,0.9830516960293509,0.32419310022082803,0.005541617503170346,"['AP2S1', 'AP2M1']",0.9999822974841958,0,0,2
332,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9860659810246059,0.228439763001975,0.0032054687518179594,['ACTG1'],0.9999822974841958,0,0,1
333,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9872096696313283,0.2238508064516129,0.0028815935719141844,['CCND1'],0.9999822974841958,0,0,1
334,Neural Crest Differentiation WP2064,0.9872096696313283,0.2238508064516129,0.0028815935719141844,['DLL3'],0.9999822974841958,0,0,1
335,T-cell receptor (TCR) signaling pathway WP69,0.9882595541917458,0.2194418089816572,0.002591587808872887,['HRAS'],0.9999822974841958,0,0,1
336,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9882595541917458,0.2194418089816572,0.002591587808872887,['CALM2'],0.9999822974841958,0,0,1
337,Nuclear Receptors Meta-Pathway WP2882,0.9898454030245584,0.4895855413621911,0.0049969580633740995,"['PSMC5', 'CCND1', 'FTH1', 'AIP', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9999822974841958,0,0,8
338,Ebola Virus Pathway on Host WP4217,0.9899080759592108,0.2941473259334006,0.0029835930182571017,"['EIF2S1', 'ACTG1']",0.9999822974841958,0,0,2
339,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9909201540346535,0.20719459378733573,0.0018898879857284802,['CCND1'],0.9999822974841958,0,0,1
340,Wnt signaling pathway and pluripotency WP399,0.9935547554879666,0.1928357897664071,0.0012468964223064734,['CCND1'],0.9999822974841958,0,0,1
341,Metapathway biotransformation Phase I and II WP702,0.9948662334427762,0.26278862705526207,0.00135257033366347,"['GPX4', 'GSTO1']",0.9999822974841958,0,0,2
342,B Cell Receptor Signaling Pathway WP23,0.9950158560314151,0.18330248545742994,0.0009158903427451887,['HRAS'],0.9999822974841958,0,0,1
343,Genes related to primary cilium development (based on CRISPR) WP4536,0.995800952144529,0.17745135688684074,0.00074669554420235,['DYNLL1'],0.9999822974841958,0,0,1
344,Wnt signaling WP428,0.9970196951636334,0.16679706307173808,0.0004978483327112197,['CCND1'],0.9999822974841958,0,0,1
345,Osteoblast differentiation WP4787,0.9972644963677857,0.16432934060721063,0.0004501394682689504,['DLL3'],0.9999822974841958,0,0,1
346,ESC Pluripotency Pathways WP3931,0.9974891885184043,0.16193314633006078,0.00040709488644927606,['HRAS'],0.9999822974841958,0,0,1
347,Pathways Regulating Hippo Signaling WP4540,0.9974891885184043,0.16193314633006078,0.00040709488644927606,['KIT'],0.9999822974841958,0,0,1
348,MAPK Signaling Pathway WP382,0.9976189846122666,0.3567489359493408,0.0008504375607686638,"['RRAS', 'GADD45A', 'DDIT3', 'RAC3', 'HRAS']",0.9999822974841958,0,0,5
349,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9976954217888652,0.15960541474654377,0.0003682476521325547,['HRAS'],0.9999822974841958,0,0,1
350,Male infertility WP4673,0.9978847112000229,0.1573432530667878,0.0003331789301580039,['PEX10'],0.9999822974841958,0,0,1
351,Regulation of toll-like receptor signaling pathway WP1449,0.9992432347623694,0.13444908666925767,0.00010178491352407946,['CUEDC2'],0.9999822974841958,0,0,1
352,"GPCRs, Class A Rhodopsin-like WP455",0.9997033505543528,0.1824783709119783,5.414013829174316e-05,"['GPR22', 'HCRTR1']",0.9999822974841958,0,0,2
353,Ciliopathies WP4803,0.9999822974841958,0.08614653663415854,1.5250239246667064e-06,['CCDC28B'],0.9999822974841958,0,0,1
